ContraFect Announces Funding Agreement with the Cystic Fibrosis Foundation
YONKERS, New York, Aug. 25, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery […]
YONKERS, New York, Aug. 25, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery […]
3.8-point mean improvement on the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale was statistically significant vs. placebo (p = […]
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) — AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present […]
MONTREAL and BOCA RATON, Fla, Aug. 25, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) and TherapeuticsMD, Inc. […]
TORONTO, Aug. 25, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the […]
Highlights:An Intersection grading 20.4 g/t Au over 2.0 m, included within a mineralized interval of 18.0 m at 2.7 g/t Au, was […]
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
SAN DIEGO, Aug. 25, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the […]
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) — Norseman Capital Ltd. (“Norseman” or the “Company”) (TSXV:NOC) announces that it […]
SHENZHEN, China, Aug. 25, 2020 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator in […]